CN114127860A - 用于确定对象的葡萄糖改变的方法和系统 - Google Patents

用于确定对象的葡萄糖改变的方法和系统 Download PDF

Info

Publication number
CN114127860A
CN114127860A CN202080049736.1A CN202080049736A CN114127860A CN 114127860 A CN114127860 A CN 114127860A CN 202080049736 A CN202080049736 A CN 202080049736A CN 114127860 A CN114127860 A CN 114127860A
Authority
CN
China
Prior art keywords
meal
glucose
subject
innovation
parameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080049736.1A
Other languages
English (en)
Chinese (zh)
Inventor
法蒂 A·埃尔
A·海达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN114127860A publication Critical patent/CN114127860A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Databases & Information Systems (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202080049736.1A 2019-07-09 2020-07-09 用于确定对象的葡萄糖改变的方法和系统 Pending CN114127860A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871931P 2019-07-09 2019-07-09
US62/871931 2019-07-09
PCT/IB2020/056467 WO2021005552A1 (en) 2019-07-09 2020-07-09 Method and system for determining glucose change in a subject

Publications (1)

Publication Number Publication Date
CN114127860A true CN114127860A (zh) 2022-03-01

Family

ID=74114442

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080049736.1A Pending CN114127860A (zh) 2019-07-09 2020-07-09 用于确定对象的葡萄糖改变的方法和系统

Country Status (7)

Country Link
US (1) US20220280720A1 (https=)
EP (1) EP3997712A4 (https=)
JP (2) JP7463491B2 (https=)
CN (1) CN114127860A (https=)
AU (2) AU2020310616A1 (https=)
CA (1) CA3146060A1 (https=)
WO (1) WO2021005552A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12569619B2 (en) * 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
WO2022169856A1 (en) * 2021-02-03 2022-08-11 Abbott Diabetes Care Inc. Systems, devices, and methods relating to medication dose guidance
FR3139456B1 (fr) * 2022-09-13 2026-02-27 Diabeloop Système permettant de compenser un repas imprévu ingéré
FR3139659B1 (fr) * 2022-09-13 2026-02-27 Diabeloop Système permettant d'estimer un repas imprévu ingéré

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575905B2 (en) * 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
AU2014349078B2 (en) * 2013-11-14 2019-07-25 Regents Of The University Of California Glucose rate increase detector: a meal detection module for the health monitoring system
US10646650B2 (en) * 2015-06-02 2020-05-12 Illinois Institute Of Technology Multivariable artificial pancreas method and system
US10478556B2 (en) * 2016-03-04 2019-11-19 Roche Diabetes Care, Inc. Probability based controller gain
US10792423B2 (en) * 2016-04-13 2020-10-06 The Trustees Of The University Of Pennsylvania Methods, systems, and computer readable media for physiology parameter-invariant meal detection
CA3198598A1 (en) * 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
WO2019125932A1 (en) * 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose

Also Published As

Publication number Publication date
EP3997712A4 (en) 2023-07-12
JP2022539818A (ja) 2022-09-13
EP3997712A1 (en) 2022-05-18
WO2021005552A1 (en) 2021-01-14
CA3146060A1 (en) 2021-01-14
JP7785832B2 (ja) 2025-12-15
JP2024099522A (ja) 2024-07-25
AU2023278117A1 (en) 2024-01-04
AU2020310616A1 (en) 2022-01-20
US20220280720A1 (en) 2022-09-08
JP7463491B2 (ja) 2024-04-08

Similar Documents

Publication Publication Date Title
US12380981B2 (en) Closed loop control of physiological glucose
US12354751B2 (en) Individualized multiple-day simulation model of type i diabetic patient decision-making for developing, testing and optimizing insulin therapies driven by glucose sensors
Pesl et al. An advanced bolus calculator for type 1 diabetes: system architecture and usability results
JP7785832B2 (ja) 被験者のグルコース変化を判定するための方法
EP3902469B1 (en) Evaluation and visualization of glycemic dysfunction
US20120246106A1 (en) Monitoring device for management of insulin delivery
CN108289642B (zh) 确定胰岛素疗法相关的参数、预测葡萄糖值和提供胰岛素给药建议的医学布置和方法
WO2015056259A1 (en) System and method for improved artificial pancreas management
Miller et al. Automatic learning algorithm for the MD-logic artificial pancreas system
JP6957509B2 (ja) 過去の予測を使用する人工膵臓のための予測制御モデル
Hu et al. An improved PID algorithm based on insulin‐on‐board estimate for Blood glucose control with type 1 diabetes
US20160162797A1 (en) Method to Determine Individualized Insulin Sensitivity and Optimal Insulin Dose by Linear Regression
Zhao et al. A safe-enhanced fully closed-loop artificial pancreas controller based on deep reinforcement learning
US20190192774A1 (en) Automatic closed-loop glucose control with an adaptive meal bolus calculator
Batora et al. Bihormonal control of blood glucose in people with type 1 diabetes
CN110352460A (zh) 人工胰腺
JP2026505427A (ja) インスリンの用量の決定におけるｑ学習の使用および関連するシステム、方法、および装置
Dias et al. Design of dual hormone blood glucose therapy and comparison with single hormone using MPC algorithm
Fravolini et al. An iterative learning strategy for the auto-tuning of the feedforward and feedback controller in type-1 diabetes
US11931548B2 (en) Method and system for determining optimal and recommended therapy parameters for diabetic subject
Al Ahdab et al. Parameter estimation for a jump diffusion model of type 2 diabetic patients in the presence of unannounced meals
Boiroux Model predictive control algorithms for pen and pump insulin administration
EP4730349A1 (en) Adaptive drug management system
Hamata et al. Exploring Equilibrium Points in a Long-term Glucose-insulin Model for Type I Diabetes: MPC Application in Automated Insulin Delivery Systems Using Functional Insulin Therapy Tools
Celik Diabetes management via Gaussian process bandits

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination